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ABSTRACT:  Retinitis is an inherited disease that affects roughly 1 in 4000 people  
worldwide.  In  this  paper  I suggest  four possible  applications of  quantum  dot 
technology in the treatment of retinitis related disorders such aș retinitis pigmentosa. 
The causes of this disease are not yet clear but it is accepted that necrotic rupture of  
the membrane and cone cell enlargement together with rod apoptosis are the main  
mechanisms of retinal cell degeneration. 
Yearly, about 1.5 million people in the world lose their sight from a disorder of 
the retina named retinitis pigmentosa (RP). The problem that this paper aims to solve 
is treating a genetic disorder, RP with the aid of quantum dot technology. A review of 
current  concepts  in  the  treatment  for  this  disorder  can  be  found  in  the  medical 
literature  [1],  and  available  treatments  range  from  gene  therapy,  retinal 
transplantation, vitamin therapy to stem cells. Recently it was found [2] that cone cells 
die by necrosis in RP while cone cells die by another mechanism that mainly involves 
membrane  rupture  and  cell  enlargement,  but  the  exact  cause  of  RP  is  yet  to  be 
elucidated. Genetic mutations of pigments of photoreceptor cells (PC) were also shown 
to produce certain forms of RP.
The retina of the human eye contains millions of PC that transform light into 
electro-chemical  signals that are processed by the brain to produce the image we 
finally perceive.  For example, the human eye contains about 130 million rods and 
about  7  million  cones.  Rod  cells  mediate  black-and-white  vision  while  cone  cells 
mediate color vision. It is known that in RP the loss of color vision due to cone cell 
death is the most debilitating part of this disease.
I suggest here some applications of quantum dots (QD) in the treatment of RP. 
These solutions have not been yet proposed in the literature. 
Quantum dot retinal implants
Having briefly introduced the anatomy of the anterior part of the retina we will  
review the technology of semiconductor quantum dots. QDs are geometrical structures 
of semiconductor crystals. A subclass of QDs are the optically active quantum dots 
(OAQDs), representing only those QDs that can interact with light quanta (photons). A 
photon creates an exciton i.e. an electron-hole pair, where by hole we understand a 
vacancy in the valence band of the semiconductor. Then an applied field along the QD 
may disintegrate the exciton via electron and hole quantum tunneling,respectively 
into electron and hole reservoirs. This in turn gives rise to a measurable photocurrent. 
Briefly, light can be converted to current using OAQD (see Fig. 1). 
It is important to mention that OAQDs can be made biocompatible and used in 
vivo. For example, quantum dots that have a spherical shape and that are made of 
CdSe are nowadays encapsulated in ZnS for keeping the toxic Cd2+ ions from being 
freed into the human body. I mention that the compound is not toxic at concentrations 
of maximum 10nM(i.e. 0.01mg/ml).  Another method used to prevent the oxidative 
release of Cd2+ ions into the human body is the polymer coating of the QDs [3].  The 
resulting  compound  can  thus  be  made  biocompatible  at  even  greater  solution 
concentrations: 1  μM (i.e. 1mg/ml).  The previously fabricated QDs were still found to 
be unstable at room temperature.
The cell experiments in [4] revealed that chitosan (CS) coated QDs (CS-ZnS and CS-
ZnS:Mn2+)  showed  low  cytotoxicity  and  good  biocompatibility  making  them 
convenient for in vivo use. 
After the coating of the quantum dots made of ZnS or ZnS: Mn2+ with a hidrophilic 
coating  such  as  chitosan  I propose  that  the  QDs to  be  further  conjugated  with 
streptavidin molecule that attach to the biotinylated anti-rhodopsin. 
In  [5]  shows  that  by  covalently  linking  phenothiazine  (PTZ)  through 
phenyldithiocarbamate (PTC) to a QD made of CdS we can allow outside tunneling of 
holes on a subpicosecond timescale. In [6] it was reported that ZnS QDs can also be 
linked to PTZ in order to make possible the hole tunneling. Using molecular electrons 
acceptors that are physiosorbed on the QD surface, electrons can tunnel outside into 
the surrounding solution on the single-picosecond timescale.
The solution of QDs will target the damaged PC cells in the retina if they are inserted 
in the  retina. The insertion  is not harmful to the body if less than 2x109 of QDs are 
injected[7].  The compunds arrives at the place of the ruptured membrane of the PC 
and insert themselves into the plasmalema of the PC because rhodopsin pigments are 
to be found there. Then the bias of chemical potentials between the extracellular fluid 
and the intracellular  fluid  transforms the impinging light  quanta (coming from the 
aqueuos  vitreous)  into  a  photocurrent.  This  current  gives  rise  to  a  graded  action 
potential along the PC thus restoring the function of the previously unhealthy cell.
I assume that the photocurrent induced by the exciton generating light should be of 
the range of  pA while the bias between extracellular fluid and intracellular fluid is 
expected to be of about several mV. About 103 photons impinging per second on a PC 
will generate tens pA of current across the membrane which should be sufficient to 
give rise to a graded action potențial.
I mention that there are three types of  anti-bodies for the three types of rhodopsin 
found in a cone cell. They facilitate the binding to the pigment with the right color. In 
order to make the process complete QDs must be grown in three sizes, depending on 
the  detected wavelength of the absorbed photon.
One remark is that one has to ensure itself that a QD compound from the colloidal  
solution has a  low enough molecular mass to permit the crossing of the blood-retina-
barrier (BRB) of the solution. This should not present an impediment în the case of 
diabetic retinitis where BRB is highly permeable.
The  suggested  treatment  în  this  section  involves  the  restoring  of  the  dead  PC. 
Colloidal OAQDs made of ZnS, coated with hidrophylic chains of chitosans and then 
conjugated  with  streptavidin,  biotin  and  anti-bodies  should  be  able  to  target  the 
rhodopsin pigments in the retinal cone cells.  Once bound to the specific rhodopsin 
molecule in the PC the OAQD should start to function in the transport regime in which 
photons are converted to electrical signals that regenerate the lost action potential 
needed for the functioning of the retina. We hope that the solution presented in this 
section would present better prospects for rehabilitation of a patient who suffers from 
RP. 
Fig. 1: Exciton formation 
and disintegration in 
quantum dots followed by 
photocurrent generation. 
ATP synthesis using quantum dots
As we have seen in the previous sections PC are of two types: rods and cones. Rods 
mediate the color vision at high light intensity while rods mediate the black and white 
vision at low light intensity.
In RP, PC exhibit cellular enlargement, along with necrotic changes such as cellular 
swelling and mitochondrial rupture. Mitochondrial rupture leads to the depletion of ATP 
in the cone cell. Since ATP drives the pumps that generate a gradient of ions across 
the PC.  Mitochondrial rupture leads to the absence of an action potential along the PC. 
ATP is formed by the binding ADP to the phosphate (Pi), and at its hydrolization energy 
is released.
I mention here that OAQD can 
have tunable size and shape 
therefore I will consider two 
conical OAQDs (see Fig 2a). 
Light entering the eye on 
these two dots should be able 
to generate excitons (pairs of 
electron-hole). I will also 
consider that the QDs are 
made of a semiconductor 
material in which the hole’s 
effective mass is larger than 
the electron’s effective mass 
(e.g. CdTe, CdSe). Because the 
energy of a particle that is 
confined in a potential well of 
nanometric dimension is 
inverselly proportional to the 
product between the mass of 
that particle and the square of 
the length of the well, and 
Fig.  2: Two quantum dots that are used to join together ADP and 
Pi groups
because the hole’s effective mass is larger than the electron’s mass, the probability 
density of finding a hole in the QD will distribute to the vertex of the conical quantum 
dot.  The electron’s probability density will distribute towards the base of the conical 
QD. Therefore by  shining of light on these conical shaped QD we will be to generate 
electric dipoles. Two such electric dipoles will attract each other as described in Fig. 2 
b) because the lowest energy configuration is when the QDs are antisymetrical and 
alligned parallel to each other.
By surrounding the dot with ZnS, another semiconductor, we can stop the release of 
the toxic Cd2+ ions in the body. This material has a larger energy gap than CdSe 
therefore we should be able to increase the lifetime of excitons (i.e. the time between 
the generation and the recombination of the electron-hole pair). We also mention that 
the quantum dot’s structure can host more than one exciton. For simplicity we will 
refer to the core (shell) QD CdSe(Zns) that is encapsulated in cystein as QD. If an 
adenozine-diphosphate(ADP) molecule binds to the apex of a QD and a phosphate 
group binds on the margin of the base of the other QD, this would catalyze the 
reaction ADP+Pi=ATP(adenozine-triphosphate) through collisions between the two 
charged dots (Fig. 2 c).
After bringing together the ADP molecule and the Pi group by the Coulomb attraction 
of opposite charges we form the ATP molecule that should be able to be freed into the 
solution due to the energetic surplus. 
The retinal exclusion threshold for human is  76.5±1.5 kDa (6.11±0.04 nm)[8] and the 
threshold fot the blood-brain-barrier is 0.5 kDa[9] therefore the QDs must have 
dimensions between these two limits.
At the dissociation of ATP into ADP and Pi  30kJ/mol are liberated  which is the 
equivalent of 312  meV per QD. The energy gap of CdSe is 1740 meV (167 kJ/mol) 
therefore a single photon with the resonant energy has enough energy to combine 
ADP and Pi into ATP. If we take into consideration the whole system the energy that is 
left over from the two photons is 3168 meV.  This energy must be larger than the  
binding energy between ADP and dot 1 to which we add the binding energy between Pi 
and dot 2.
The decay time of an exciton in some nano-structures was shown to be as large as a 
few microseconds[10]. This means that the exciton is sufficiently persistent in order 
for the merging of the dots to occur at this scale of time. The computation of the 
minimum persistence time of an exciton can be done using the expression of the 
Coulomb potential between two charges found in a medium whose Debye-Hückel 
radius is of the order of that of the water. (i.e. 8 Å). This potential reads:
V (r )=− e
2
4 πε0 εr r
e
−r
D ,
where V(r) is the attraction potential, ε0 is the vacuum dielectric permittivity, εeff  is the 
relative permittivity of water at room temperature (i.e. 78.33),  D is the Debye-Hückel 
radius.
The mass of a dot is approximately m=60 kDa. By solving:
ma (t )=−dV (r )
dr ,
we find that the time between two consecutive bumps is τ=10 μs., Here a(t) is the 
acceleration of a dot towards their common mass center. In solving the differential 
equation the condition r(τ)=0 has to be set.
I mention that the ADP must get close enough to Pi in order for the reaction to occur. 
This distance is about 2 Å which is the breaking point of ATP [11]. Therefore the 
collision of the two QDs must bring the ADP and Pi within a distance of maximum 0.2 
nm.
In [12] it has been reported the creation of colloidal solutions of bipyramidal core/shell 
QDs of about 20nm made of CdSe/CdS. 
There remains only on further step: conjugating the dots with molecules that dock to 
ADP and Pi. For this, the initial solution of QDs must be split in two separate solutions. 
The first one will be conjugated to streptavidin and a biotinylated low affinity 
adenosine receptor A2B-R (ADORA2B). The affinity of A2B receptor is approximately Ki 
=56nM[13]. This affinity corresponds to a variation of Gibbs energy ΔG=RT ln K i  
yielding a value of 41.37 kJ/mol.
It can be shown that the electrostatic force between two dipoles is greater for parallel 
dipoles lying in different planes than the force between two collinear dipoles at the 
same distance apart. This means that the configuration of dipoles depicted in Fig. 2 is 
favoured over the case in which the two dipoles are parallel and collinear.   
There are many proteins that have binding sites for Pi but we are interested only in the 
ones that have low affinity and low molecular mass.
Two QDs that happen to be in vicinity will attract bringing thus together the ADP and 
phosphate molecules and making possible the reaction (see Fig. 2 b).  
Once they come in contact the two dots are allowed to recombine their charge carriers 
through tunneling between dots. In this way the hole of the dot recombines with the 
electron from the base of the dot in the right and vice-versa. During their contact ATP 
is formed (Fig. 2c).
After charge neutralization the two dots will separate due to Brownian motion and this 
will release the ATP (Fig. 2d).
The QDs may be pyramidal or conical CdSe/ZnS dots. A hydrophilic polymer coating is 
prefferable. One ligand should be the Anti-Adenosine Receptor A2a antibody which has 
to be biotinylated  and linked with streptavidin conjugated dots. The other ligand can 
be a PhosTag molecule conjugated in the same fashion as the previous molecule. 
ATP synthesis using fluorescence resonance energy transfer between two 
linked quantum dots
In this section I suggest another possible solution of generating ATP from ADP and Pi 
using pairs of linked QDs. Fluorescence Resonance Energy Transfer(FRET) technique 
was invented over 50 years ago and was since used for the transfer of vibrational 
energy between a donor and an acceptor molecule. The donor molecule can be a 
chromophore that absorbs the energy while the acceptor is the chromophore to which 
the energy is transferred. This phenomena are extensively used in biomedicine.  The 
advantage over the previous method is that the energy transfer within this technique 
can be done without the collision of the acceptor and the donor molecules. Two 
molecules that interact in a way that FRET occurs form a donor/acceptor pair.  The 
donor and acceptor must be close to each other (around 10-100 Å). The condition in 
order for FRET to occur between the molecules is that the spectrum of the donor 
molecule to overlap the energy spectrum of the acceptor molecule. Instead of 
molecules we can use QDs with the right energy gap.
QDs were shown to have been used as donors and acceptors but the idea that this 
transfer of energy could be used in biomedicine for treating RP was not suggested. 
The idea is the following: the energy of the photons that come in contact with the 
donor quantum dot is transmitted through resonance to the acceptor QD which is 
conjugated with anti-ADP (or anti-phosphate e.g. PhosTag) ligand molecules. Each 
phosphate gourp coming close to the energetic ADP conjugated to these ligands will 
react and form ATP. The energy that is necessary in order for this reaction to occur 
comes from the donor quantum dot. The transfer of energy between the donor and the 
acceptor dot is necessary because the frequency of light has to be converted to he 
frequency that corresponds to the ATP dissociation energy. This energy is small and 
the corresponding wavelength does not lie in the visible spectrum(E= 312  meV), 
therefore an energy conversion must occur. This conversion is guaranteed by the FRET 
of the two QDs. 
Each of the dots has also conjugated a sequence of oligonucleotide, and the two 
oligonucleotides are complementary in order for the FRET binding to occur. Once 
bound the energy transfer via FRET is allowed. 
I mention that the two QDs must have overlapping spectra and that they replace the 
mitochondrial organelle that was destroyed in the process of necrosis of the PCs. The 
donor QD and the oligonucleotide must have a total molecular weight that is smaller 
than the  maximum allowed molecular weight of the BRB. The acceptor dot and the 
conjugated streptavidin with biotinylized anti-ADP must also have an overall molecular 
of less than 76 kDa in order to pass through the BRB. One has to find right sizes of the 
dots in order for the energy transfer between the two dots to occur. 
Apoptosis reversal using quantum dots 
In this section it is suggested a method that should be able to bring back together the 
organelles of a broken PC that underwent apoptosis. 
In apoptotic regulated cell death organelles are encapsulated within their own 
membrane. Being separated from a functional point of view from other organelles the 
cell's function is therefore lost. Grouping them back piece by piece can be a daunting 
task yet it may happen from an energetic point of view because the energy 
contribution of the surface tension of individually encapsulated organelles is higher 
than the surface tension energy of the healthy intact cell. By linking the organelles 
together using a nanowire the organelles can be brought back together. The 
organelles are to be found at  6 microns apart after one minute of apoptosis according 
to the Brownian law of motion. If the nanowires have radii of about 15 nanometers 
then their height has to be about 2 micrometers in order for the water in the 
cytoplasm of an organelle to climb up along the dot and connect with the other 
organelle. In order to make the coalescing of organelles more feasible the dot that was 
introduced earlier has to be broken down in two parts, each one of about 1 micrometer 
in length and each one of them having to be able to anchor itself on the membrane of 
one part of the broken cell to be further joined. If the dot is further made of magnetite 
which is a magnetic biodegradable material the two parts should attract each other 
and unite into a bridge (see Fig. 3c) 
In conclusion a nanowire made of magnetite should be able to conjugate its end to the 
membrane of the cell’s organelles that underwent apoptosis. Two such nanowires 
should attract each other by the other free magnetic end. Two nanowires should have 
opposites poles in order for the coalescing to occur. Therefore the place of the 
anchored ligands are inverted.
Fig. 3: Two magnetite quantum dots used to join together organelles after apoptosis 
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